TGFB1 and neoplasm: The depletion of Tregs in both blood and primary tumors was accompanied by a reduction of myofibroblasts and EMT markers in the tumor and lung, which may be explained by the low level of TGF-β and downregulation of TGF-β receptor 2 (TGFβRII).